Tim Roy Cressey

19PUBLICATIONS
112CO-AUTHORS
Adolescent healthPharmacogenomicsInfant and child healthNeonatologyEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Feb 24, 2026
SHIELD study: a multicenter, open-label, single-arm trial to evaluate the safety, pharmacokinetics and antiviral activity of fostemsavir in combination with optimized background therapy (OBT) in children and adolescents with HIV who are failing their current combination antiretroviral therapy (cART) and have dual- or triple-class antiretroviral (ARV) resistance.

Carlos Grasa, Nicolas Salvadori, Alessandra Nardone

|Dec 29, 2025
Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).

Adrie Bekker, Navarat Panjasawatwong, Louise F Hill

|Sep 06, 2025
Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in Young Children With Chronic HCV Infection.

Ahmed N Farrag, Maggie M Abbassi, Nirmeen A Sabry

|Jul 31, 2025
Pharmacokinetics of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum with and without efavirenz-based antiretroviral treatment: IMPAACT P1026s study.

Marije Van Schalkwyk, Adrie Bekker, Eric Decloedt

|May 29, 2025
Efficacy, Safety and Tolerability of Dispersible and Immediate Release Abacavir/Dolutegravir/Lamivudine Tablets in Children With HIV: IMPAACT 2019 Week 48 Results.

Helena Rabie, Dwight E Yin, Shawn Ward

|Feb 20, 2025
Single Doses of Pediatric Dolutegravir Dispersible Tablets in Neonates Support Multidosing: PETITE-Dolutegravir Study.

Tim R Cressey, Nicolas Salvadori, Helena Rabie

Pageof 4

Frequent Collaborators

4 joint publications

Nicolas Salvadori

3 joint publications

Kulkanya Chokephaibulkit

2 joint publications

Gonzague Jourdain

2 joint publications

Adrie Bekker